| 0 |
SENSITISATION |
6 |
0.0079 |
| 1 |
EJECTION FRACTION |
4 |
0.0069 |
| 2 |
EJECTION FRACTION ABNORMAL |
6 |
0.0049 |
| 3 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
6 |
0.0041 |
| 4 |
POLYCYSTIC OVARIES |
6 |
0.0039 |
| 5 |
NEPHRECTOMY |
5 |
0.0034 |
| 6 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 7 |
RHINITIS ALLERGIC |
6 |
0.0013 |
| 8 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
5 |
0.0008 |
| 9 |
AGORAPHOBIA |
1 |
0.0007 |
| 10 |
FULL BLOOD COUNT ABNORMAL |
6 |
0.0006 |
| 11 |
CARPAL TUNNEL SYNDROME |
6 |
0.0004 |
| 12 |
BLOOD TEST ABNORMAL |
6 |
0.0004 |
| 13 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 14 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
6 |
0.0004 |
| 15 |
NEPHROPATHY |
3 |
0.0003 |
| 16 |
LYME DISEASE |
1 |
0.0003 |
| 17 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 18 |
FIBROMYALGIA |
6 |
0.0002 |
| 19 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 20 |
HYPOTHYROIDISM |
6 |
0.0002 |
| 21 |
CATARACT OPERATION |
1 |
0.0002 |
| 22 |
PLEURISY |
1 |
0.0002 |
| 23 |
HEPATITIS B |
1 |
0.0002 |
| 24 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 25 |
SOMNAMBULISM |
1 |
0.0002 |
| 26 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 27 |
RENAL DISORDER |
6 |
0.0001 |
| 28 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
6 |
0.0001 |
| 29 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 30 |
WHEEZING |
6 |
0.0001 |
| 31 |
EUPHORIC MOOD |
1 |
0.0001 |
| 32 |
GASTROOESOPHAGEAL REFLUX DISEASE |
7 |
0.0001 |
| 33 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 34 |
NIGHTMARE |
3 |
0.0001 |
| 35 |
BURNING SENSATION |
6 |
0.0001 |
| 36 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
0.0001 |
| 37 |
POLYNEUROPATHY |
1 |
0.0001 |
| 38 |
APPLICATION SITE ERYTHEMA |
2 |
0.0001 |
| 39 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 40 |
HUNGER |
1 |
0.0001 |
| 41 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 42 |
CARDIAC DISORDER |
6 |
0.0001 |
| 43 |
MANIA |
1 |
0.0001 |
| 44 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 45 |
LOCAL SWELLING |
1 |
0.0001 |
| 46 |
COLD SWEAT |
1 |
0.0001 |
| 47 |
ADVERSE EVENT |
5 |
0.0001 |
| 48 |
ASTHMA |
6 |
0.0001 |
| 49 |
SINUS DISORDER |
1 |
0.0001 |
| 50 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 51 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 52 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 53 |
AGEUSIA |
1 |
0.0000 |
| 54 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 55 |
EYE PAIN |
2 |
0.0000 |
| 56 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 57 |
EYE IRRITATION |
2 |
0.0000 |
| 58 |
HOSPITALISATION |
5 |
0.0000 |
| 59 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 60 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 61 |
FUNGAL INFECTION |
1 |
0.0000 |
| 62 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 63 |
SLEEP DISORDER |
2 |
0.0000 |
| 64 |
HYPERTENSION |
6 |
0.0000 |
| 65 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 66 |
RESTLESSNESS |
1 |
0.0000 |
| 67 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 68 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 69 |
COMA |
1 |
0.0000 |
| 70 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 71 |
SPEECH DISORDER |
1 |
0.0000 |
| 72 |
DYSPNOEA |
10 |
0.0000 |
| 73 |
HEADACHE |
11 |
0.0000 |
| 74 |
COVID-19 |
3 |
0.0000 |
| 75 |
IRRITABILITY |
1 |
0.0000 |
| 76 |
INSOMNIA |
4 |
0.0000 |
| 77 |
VISION BLURRED |
2 |
0.0000 |
| 78 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 79 |
OVERDOSE |
3 |
0.0000 |
| 80 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 81 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 82 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 83 |
MALAISE |
5 |
0.0000 |
| 84 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 85 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 86 |
DYSPEPSIA |
1 |
0.0000 |
| 87 |
SINUSITIS |
1 |
0.0000 |
| 88 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 89 |
HAEMORRHAGE |
1 |
0.0000 |
| 90 |
INFLUENZA |
1 |
0.0000 |
| 91 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 92 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 93 |
BACK PAIN |
2 |
0.0000 |
| 94 |
CHILLS |
1 |
0.0000 |
| 95 |
ASTHENIA |
3 |
0.0000 |
| 96 |
HYPERHIDROSIS |
1 |
0.0000 |
| 97 |
RENAL FAILURE |
1 |
0.0000 |
| 98 |
NEUTROPENIA |
1 |
0.0000 |
| 99 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 100 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 101 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 102 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 103 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 104 |
SOMNOLENCE |
1 |
0.0000 |
| 105 |
CONSTIPATION |
1 |
0.0000 |
| 106 |
DECREASED APPETITE |
1 |
0.0000 |
| 107 |
VOMITING |
2 |
0.0000 |
| 108 |
FEELING ABNORMAL |
1 |
0.0000 |
| 109 |
NAUSEA |
3 |
0.0000 |
| 110 |
COUGH |
1 |
0.0000 |
| 111 |
ANXIETY |
1 |
0.0000 |
| 112 |
PNEUMONIA |
1 |
0.0000 |
| 113 |
FALL |
1 |
0.0000 |
| 114 |
PYREXIA |
1 |
0.0000 |
| 115 |
FATIGUE |
2 |
0.0000 |
| 116 |
DIARRHOEA |
1 |
0.0000 |
| 117 |
DEATH |
1 |
0.0000 |
| 118 |
OFF LABEL USE |
1 |
0.0000 |